Immunity for Health: Vaccines & Immunotherapy

16–17 Oct 2024 | RodeBol Events

Fernando Ulloa Montoya

Head mRNA Data and Computational Sciences, Sanofi

Sanofi

Tervuren, Belgium

12 profile visitsSpeakerSpeaker

About me

My organisation

Sanofi

Sanofi

Additional questions

How would you categorise yourself?

Vaccine manufacturerHigher management

Organisation Type

Pharma industry

Areas of expertise

Personalised medicineDigital health and technologyResearch and developmentImmunotherapy R&DVaccine R&D

Therapeutic areas

Infectious diseases Oncology

1. I accept the General Terms & Conditions and Privacy Statement, available on flandersvaccine.be and agree that pictures can be taken at the event and be used for Flanders Vaccine communication purposes.

I agree

Speaker sessions (2)

Thursday, 17 October 2024

10:10 - 10:35

The use of Artificial Intelligence and Machine Learning (AI/ML) in the development of mRNA vaccines - Fernando Ulloa Montoya, Sanofi

Format:In-person

AI&ML and mechanistic modeling allow us to tackle the complex combinatorial problem of mRNA sequence, lipid nano-particles design and process development to optimize critical quality attributes and immune response of mRNA vaccines